H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
TAMPA, FL, 33612
Prime contracting experience
7 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 | HHSN268201400003IUSAspending | $12,953,436 | Dec 31, 2025 | Aug 30, 2016 – Feb 28, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0025-01: FVIII TCR-ENGINEERED TREG CELL PRODUCT | HHSN268201600013IUSAspending | $761,385 | Dec 1, 2025 | Jun 3, 2019 – Mar 31, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR RSA PCT0002-02: LOVO PACT CENTER STUDY | HHSN268201600013IUSAspending | $525,665 | Nov 18, 2025 | Oct 31, 2018 – Jun 1, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES | HHSN268201600013IUSAspending | $668,301 | Jun 13, 2025 | Aug 1, 2016 – Jun 30, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY | HHSN268201400003IUSAspending | $1,317,909 | Mar 27, 2024 | Sep 1, 2015 – Jun 29, 2018 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES | HHSN268201600013IUSAspending | $474,454 | Feb 21, 2024 | Jun 29, 2018 – Apr 29, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY- CENTRAL LABORATORY AND BIOREPOSITORY | HHSN268201400003IUSAspending | $928,451 | Feb 16, 2024 | Sep 4, 2014 – Sep 3, 2016 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
1 record from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | GENERATION OF X-RAY STRUCTURES WITH A LIGAND BOUND TO ALDH1A1 AND ALDH1A2. PO103062 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: CA Parent award description: AWARD TASK ORDER 3 : PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY View parent award on USAspending | 75N94023D00006USAspending | $211,105 | Feb 7, 2025 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.